Search
for
Sort by
Research 391–420 of 1000+
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Hair
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- From Misdiagnosis to Targeted Therapy: A Case Report of Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Evidence for the off-label use of tofacitinib in alopecia areata
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- JAK inhibitors and alopecia areata
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases